CompletedPhase 4

Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer

China1,184 participantsStarted 2010-05

Plain-language summary

This is a self-controlled, open, multiple-center clinical trial.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Age is over 18 years old , men or women
✓. Erosive lesions or flat lesions with thin white coating in acute gastritis, acute stage of chronic gastritis with over three lesions (including three lesions) by endoscopy prior to study in 3 days or diagnosed by clinical symptoms and signs;
✓. Signed the informed consent forms.

✕. Patients without inclusion criteria
✕. Patients with significant cardiovascular, pulmonary, hepatic, renal or hemopoietic system primary disease
✕. Patients with other digestive diseases.
✕. Patients with operation on stomach and duodenum.
✕. Patients administered with nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids
✕. Patients with severity trauma, surgery, infection and shock.
✕. Patients with any kind of tumor
✕. Women either pregnant or breast feeding

Endoscopic results of ulcer lesion

Timeframe: 56 days

Total effective rate

Timeframe: 56 days.

NCT IDNCT01190657

SponsorEisai Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2013-02